表紙
市場調查報告書

數位療法 (Digital Therapeutics) 美國市場預測:∼2023年

US Digital Therapeutics Market, Forecast to 2023

出版商 Frost & Sullivan 商品編碼 648619
出版日期 內容資訊 英文 143 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
數位療法 (Digital Therapeutics) 美國市場預測:∼2023年 US Digital Therapeutics Market, Forecast to 2023
出版日期: 2018年05月25日內容資訊: 英文 143 Pages
簡介

數位療法 (Digital Therapeutics)市場預測期間預估將有30.7%CAGR (年複合成長率) 成長。

本報告針對美國數位療法 (Digital Therapeutics) 市場調查、提供市場定義與概要、生態系統、商業模式、部門分類收益規模推算與預測、技術動向與藍圖、競爭環境、主要參與企業檔案、成功策略、成長機會分析、未來展望。

第1章 摘要整理

第2章 數位療法市場:確實的機會定義

  • 數位保健市場區分
  • 數位療法起源
  • 數位療法
  • 主要定義
  • 數位保健的數位療法定位
  • 行動保健與數位保健的不同數位療法
  • 關心數位療法的醫藥企業
  • 數位療法與醫藥企業
  • 數位保健:行動保健的進化
  • 被各種因素推動的行動保健市場
  • 數位療法:技術動向與藍圖

第3章 初期數位療法市場

  • 市場區分
  • 分類
  • 數位療法、進步領域
  • 數位療法同盟
  • FDAソPreCert(Digital Health Software Precertification)方案

第4章 市場預測、市場動向

  • 行銷工程測定
  • 預測前題因素
  • 單一經營數位療法市場:收益預測
  • 單一經營數位療法市場:收益預測相關討論
  • 整體市場:收益預測
  • 整體市場:收益預測相關討論
  • 整體市場:收益預測:部門分類
  • 整體市場:收益佔有率:部門分類
  • 整體市場:收益佔有率預測:部門分類
  • 慢性症狀管理部門:收益預測
  • 慢性症狀管理部門:收益預測相關討論
  • 行動管理部門:收益預測
  • 行動管理部門:收益預測相關討論
  • 用藥遵守支援部門:收益預測
  • 用藥遵守支援部門:收益預測相關討論
  • 數據收集與分析部門:收益預測
  • 數據收集與分析部門:收益預測相關討論

第5章 競爭環境

  • 競爭市場構造
  • 競爭力學
  • 數位療法生態系統
  • 數位療法:目前買家與潛在顧客
  • 商業模式
  • 專業-顧客光譜
  • 供應商生態系統

第6章 數位療法的單一經營企業

  • Pear Therapeutics
  • WellDoc
  • Chrono Therapeutics
  • Omada Health
  • Proteus Digital Health
  • Noom Inc.
  • mySugr (Roche Diabetes Care)
  • Click Therapeutics
  • Canary Health
  • CellScope
  • Virta Health

第7章 連接市場的參與企業

  • AliveCor
  • Apple, Inc.
  • Oscar Health Insurance Corporation
  • Big Health Ltd. (Sleepio)

第8章 數位服務與設備企業

  • 醫療設備企業與數位療法
  • 生活方式服務企業與數位療法
  • 保險者與數位療法
  • 數位醫藥投資檔案

第9章 其他參與企業:數位療法倡議

第10章 成長機會

  • 未來策略、重要成長機會
  • 成長方法
  • 成長機會:數位療法定義
  • 成長機會:數位療法認知度提升
  • 成長機會:商業模式架構
  • 成長機會:開發可應對更多症狀的方法
  • 成長機會:強化數據
  • 策略必須條件

第11章 未來展望

  • 技術:對數位療法影響
  • 三大預測

第12章 附錄

第13章 關於FROST & SULLIVAN

目錄
Product Code: K270-48

Many New Services Evolving from Digital Health and mHealth are Expected to Drive Growth, Reduce Healthcare Costs, and Improve Patient Outcomes

Digital therapeutics are about to become a true medical alternative that will utilize communications-based technologies, apps, and software to improve patient outcomes and help to lower the cost of healthcare. The overall digital therapeutics market is expected to grow at a compound annual growth rate of 30.7% from 2017 to 2023.

This report emphasizes the importance of clearly defining the term "digital therapeutics." In many areas of the evolving healthcare market, an important facet of understanding opportunity and strategy is effective definition and scoping of new terminology and concepts. Frost & Sullivan reviews data that illustrate there is often an inconsistent definition of the term as well as the companies that are participating in this early market. The research reveals that there is a much smaller segment of the digital therapeutics market devoted to pure play participants that are developing true therapeutic solutions that will provide a medical-grade benefit to patients. The pure play market will require considerable research and development in partnership with pharmaceutical companies, and a US Food and Drug Administration certification for safety and efficacy after a clinical trial.

Frost & Sullivan predicts that the digital therapeutics market will attract the interests of medical device companies, pharmaceutical industry participants, and investors. It is reasonable to foresee that several of the larger, established healthcare companies will carefully monitor progress in this space and make strategic moves as the smaller, new entrants demonstrate successful outcomes following randomized clinical trials.

Research Scope:

The objective of this research service is to present an analysis of the US digital therapeutics market with respect to key market dynamics at play through 2023 and showcase select areas of opportunity in a landscape of related segments. The study describes and defines the digital therapeutics market and enabling technology; covers factors driving the need to deploy this emerging solution to enable improved patient outcome-based drug replacement, drug augmentation, and interactive communications platforms across a variety of specialties; examines challenges impacting the market; presents an outlook for the adoption of digital therapeutic services among key customer segments; presents Frost & Sullivan forecasts for overall market growth; and looks at opportunities in the total market and key market segments as estimated for the forecast period.

Key Issues Addressed:

  • What are pure play digital therapeutic services, and how are these solutions being deployed to patients, healthcare payers, employer plans, hospitals and physicians?
  • What are the market-shifting macro trends affecting the need to deploy new digital therapeutic solutions to enable patients to achieve quality care in a variety of settings?
  • What companies have a presence in the digital therapeutics market, either as pure play participants or within the wider view of the market?
  • What are the segments of the digital therapeutics and digital health-related market, and which ones offer the best opportunities for growth?
  • What is the 6-year revenue outlook for the digital therapeutics market and the major segments?

Table of Contents

1. EXECUTIVE SUMMARY

  • Key Findings
  • Key Findings (continued)
  • Key Findings (continued)
  • Key Findings (continued)
  • Scope and Segmentation
  • Key Questions This Study Will Answer
  • Market Engineering Measurements
  • CEO's Perspective
  • 3 Big Predictions

2. DIGITAL THERAPEUTICS MARKET-DEFINING A PROMISING OPPORTUNITY

  • Digital Health Market Segmentation
  • Digital Therapeutics Origin
  • Digital Therapeutics
  • Key Definitions
  • Digital Therapeutics' Position in Digital Health
  • Digital Therapeutics is Neither mHealth nor Digital Health
  • Pharma is Increasingly Interested in Digital Therapeutics
  • Digital Therapeutics and Pharmaceutical Companies
  • Digital Health Is Evolving from mHealth
  • mHealth Market Has Been Driven by Various Forces
  • Digital Health-Highest Impact Segments on Healthcare
  • Foundation for Digital Health and Therapeutics
  • Digital Therapeutics Technology Trends and Roadmap

3. THE EARLY DIGITAL THERAPEUTICS MARKET

  • Market Segmentation
  • Breaking Down the Segments
  • Digital Therapeutics and Health Areas of Progress
  • Digital Therapeutics Alliance
  • FDA Digital Health Software Precertification Program

4. FORECASTS AND TRENDS-TOTAL MARKET AND SEGMENT ANALYSIS

  • Market Engineering Measurements
  • Forecast Assumptions and Considerations
  • Full-Scale Market and Pure Play Solution Attributes
  • Pure Play Digital Therapeutics Market-Revenue Forecast
  • Pure Play Digital Therapeutics Market-Revenue Forecast Discussion
  • Total Digital Therapeutics Market-Revenue Forecast
  • Total Digital Therapeutics Market-Revenue Forecast Discussion
  • Total Digital Therapeutics Market-Revenue Forecast by Segment
  • Total Digital Therapeutics Market-Revenue Share by Segment
  • Total Digital Therapeutics Market-Revenue Share Forecast by Segment
  • Chronic Condition Management Segment-Revenue Forecast
  • Chronic Condition Management Segment-Revenue Forecast Discussion
  • Behavior Management Segment-Revenue Forecast
  • Behavior Management Segment-Revenue Forecast Discussion
  • Medication Adherence Support Segment-Revenue Forecast
  • Medication Adherence Support Segment-Revenue Forecast Discussion
  • Data Gathering and Analytics Segment-Revenue Forecast
  • Data Gathering and Analytics Segment-Revenue Forecast Discussion

5. COMPETITIVE ENVIRONMENT

  • Competitive Market Structure
  • Competitive Dynamics
  • The Digital Therapeutics Ecosystem-Technologies Add Value to Traditional Prescription-Based Treatments
  • Digital Therapeutics-Current and Potential Buyers
  • Business Models in Digital Therapeutics
  • Professional-Consumer Spectrum
  • Vendor Ecosystem

6. PURE PLAY DIGITAL THERAPEUTICS COMPANIES

  • Pear Therapeutics
  • WellDoc
  • Chrono Therapeutics
  • Omada Health
  • Proteus Digital Health
  • Noom Inc.
  • MySugr (Roche Diabetes Care)
  • Click Therapeutics
  • Canary Health
  • CellScope
  • Virta Health

7. ADJACENT MARKET PARTICIPANTS

  • AliveCor
  • Apple, Inc.
  • Oscar Health Insurance Corporation
  • Big Health Ltd. (Sleepio)

8. DIGITAL SERVICES AND DEVICE COMPANIES

  • Medical Device Companies and Digital Therapeutics
  • Medical Device Companies and Digital Therapeutics (continued)
  • Lifestyle Services Companies and Digital Therapeutics
  • Payer Focused on Digital Therapeutics
  • Digital Medicine Investment Portfolio

9. ADDITIONAL MARKET ENTRANTS-DIGITAL THERAPEUTICS INITIATIVES

  • Additional Digital Therapeutics Companies
  • Additional Digital Therapeutics Companies (continued)
  • Additional Digital Therapeutics Companies (continued)
  • Additional Digital Therapeutics Companies (continued)
  • Additional Digital Therapeutics Companies (continued)
  • Additional Digital Therapeutics Companies (continued)
  • Additional Digital Therapeutics Companies (continued)
  • Additional Digital Therapeutics Companies (continued)
  • Additional Digital Therapeutics Companies (continued)
  • Additional Digital Therapeutics Companies (continued)
  • Additional Digital Therapeutics Companies (continued)
  • Additional Digital Therapeutics Companies (continued)
  • Additional Digital Therapeutics Companies (continued)
  • Additional Digital Therapeutics Companies (continued)
  • Additional Digital Therapeutics Companies (continued)
  • Additional Digital Therapeutics Companies (continued)
  • Additional Digital Therapeutics Companies (continued)
  • Additional Digital Therapeutics Companies (continued)
  • Additional Digital Therapeutics Companies (continued)
  • Additional Digital Therapeutics Companies (continued)
  • Additional Digital Therapeutics Companies (continued)
  • Additional Digital Therapeutics Companies (continued)
  • Additional Digital Therapeutics Companies (continued)
  • Additional Digital Therapeutics Companies (continued)

10. GROWTH OPPORTUNITIES

  • 5 Growth Opportunities Critical for Future Strategies
  • Levers for Growth
  • Growth Opportunity 1-Define Digital Therapeutics
  • Growth Opportunity 2-Increase Awareness of Digital Therapeutics
  • Growth Opportunity 3-Develop Business Models
  • Growth Opportunity 4-Develop Solutions for More Conditions
  • Growth Opportunity 5-Harness the Data
  • Strategic Imperatives for Digital Therapeutics

11. FUTURE PERSPECTIVES

  • Technology-Future Impact on Digital Therapeutics
  • 3 Big Predictions
  • Legal Disclaimer

12. APPENDIX

  • List of Exhibits
  • List of Exhibits (continued)
  • Additional Frost & Sullivan Coverage of Telehealth
  • Selected Sources
  • Selected Sources (continued)
  • Selected Sources (continued)

13. THE FROST & SULLIVAN STORY

  • The Frost & Sullivan Story
  • Value Proposition-Future of Your Company & Career
  • Global Perspective
  • Industry Convergence
  • 360° Research Perspective
  • Implementation Excellence
  • Our Blue Ocean Strategy
Back to Top